To further dissect which type of estrogen receptor (ER) is involved in the estrogen-promoted prostatic fibrosis of BPH patients with accelerated progression, we examined the expression of ERα, ERβ, and GPER in the three groups. This evidence concerns the gene ESR2 and benign prostatic hyperplasia.